Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Triamcinolone acetonide injections help regrow hair in alopecia areata patients.

This study reports that hair regrowth is observed in 64-97% of adult patients with patchy alopecia areata treated with intralesional triamcinolone acetonide injections.

Cicatricial alopecia can progress to complete hair loss, making diagnosis and management difficult.

This study developed a grooved microneedle platform enabling precise transdermal delivery of triamcinolone acetonide for alopecia areata, achieving accurate dosing by controlling groove position and drug concentration.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

This review discusses the immune-mediated mechanism behind alopecia areata, highlighting similarities between the condition in humans and animals, and reports no new clinical results.

This review outlines the applications of intralesional steroid therapy, particularly triamcinolone acetonide, in several dermatological conditions and suggests further trials for certain uses but reports no new clinical findings.

This study found no overall difference in effectiveness between fractional CO2 laser and microneedling for resistant alopecia areata, although the laser group showed a statistically significant early response in terminal hair regrowth.

Cimetidine is not a first-choice treatment for female hair loss, and there's no consistently successful treatment for this condition in men or normal hormone level women.

This article is a reply to Dr. Greenwald and does not provide new clinical results.

This article reports a case where a man's hair regrew after treating actinic keratosis with fluorouracil, suggesting a possible unexpected effect of the treatment.

This article critiques the dosages recommended by Dr. Orentreich for alopecia treatment, suggesting higher initial dosages of prednisone and intralesional steroids may be more effective based on the author's experiences.

This study reports that emotional distress may cause alopecia areata and that treatments like fluorinated corticosteroid cream and triamcinolone acetonide injections have varying success, with hair regrowth being less frequent in children.

This review suggests that platelet-rich plasma may be a promising treatment for immune-mediated alopecias, including alopecia areata and primary cicatricial alopecias, but definitive recommendations are limited due to insufficient high-quality evidence.

This study found that among an Asian population with alopecia areata, commonly first episodes occurred before age 40, with severe cases linked to psychological effects and treatments showing significant regrowth.

This study observed that frontal fibrosing alopecia predominantly affects postmenopausal women, can be associated with lichen planus, and may lead to progressive hairline recession, though this progression is not consistent in all cases.

This review discusses evidence-based guidance for managing primary cicatricial alopecias but reports no new clinical results, highlighting significant gaps in knowledge and the need for more quality trials.

This review discusses various treatments for alopecia areata, highlighting their limitations and individualized approach, and reports no new clinical results.

This case report describes a patient with corticosteroid-resistant ophiasis alopecia areata who experienced prompt hair regrowth after receiving platelet-rich plasma injections.

This review discusses the classification and diagnosis of primary cicatricial alopecias and reports no new clinical results; it highlights the need for effective treatments owing to limited evidence of current therapies' efficacy.

This article includes no new results; it discusses ongoing treatment approaches for frontal fibrosing alopecia and lichen planopilaris.

In this report, a case of steroid-resistant multifocal alopecia areata was successfully treated with topical bimatoprost, suggesting it may be a promising alternative therapy.

In this study, intralesional triamcinolone acetonide injections were associated with halting the progression of frontal fibrosing alopecia in female patients and showed minimal adverse effects, but the efficacy as sole therapy remains unclear pending further trials.

This letter details 11 cases of scalp pseudocyst treated primarily with intralesional triamcinolone, resulting in complete hair regrowth in eight patients and self-resolution in some instances.

This study reports cases of histopathologically proven cutaneous lupus erythematosus manifesting as frontal fibrosing alopecia, with improvement following treatment with oral hydroxychloroquine and/or intralesional triamcinolone acetonide.

In this case report, a 37-year-old man with discoid lupus erythematosus experienced around 80% hair regrowth after treatment with a combination of oral and topical therapies.

In this case report, the researchers described two women with Crohn disease who developed alopecia related to TNF inhibitor therapy, noting various histopathological features of drug-induced alopecia and treating it effectively with different therapeutic approaches.

This article reviews the challenges of treating frontal fibrosing alopecia and the potential role of hair transplantation, noting the lack of effective medical treatments and uncertainty surrounding transplant outcomes.

This article reviews five cases of primary idiopathic pseudopelade of Brocq and reports no histopathological changes indicative of any specific cicatricial alopecia.

This article details the treatment of a 56-year-old woman with female pattern hair loss using finasteride and minoxidil but reports no new findings.